Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 172821, 7 pages
http://dx.doi.org/10.1155/2014/172821
Review Article

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease

1Département d'Hépatogastroentérologie, Hôpital Saint-Eloi, Centre Hospitalier Universitaire de Montpellier, 80 Avenue Augustin Fliche, 34295 Montpellier, France
2Département d’Immunologie, Hôpital Saint-Eloi, Centre Hospitalier Universitaire de Montpellier, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France

Received 28 June 2013; Revised 15 January 2014; Accepted 17 February 2014; Published 18 March 2014

Academic Editor: Sophie Desplat-Jégo

Copyright © 2014 Romain Altwegg and Thierry Vincent. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Pedro J. Gonzalez-Cabrera, Steve Brown, Sean M. Studer, and Hugh Rosen, “S1P signaling: New therapies and opportunities,” F1000Prime Reports, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Tomasz J. Ślebioda, and Zbigniew Kmieć, “Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease,” Mediators of Inflammation, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Francesca Algieri, Alba Rodriguez-Nogales, M. Elena Rodriguez-Cabezas, Severiano Risco, M. Angeles Ocete, and Julio Galvez, “Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review,” Mediators of Inflammation, vol. 2015, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Jesse Lyons, Charles A. Herring, Amrita Banerjee, Alan J. Simmons, and Ken S. Lau, “Multiscale analysis of the murine intestine for modeling human diseases,” Integr. Biol., vol. 7, no. 7, pp. 740–757, 2015. View at Publisher · View at Google Scholar
  • Filipa Silva-Ferreira, Joana Afonso, Pedro Pinto-Lopes, and Fernando Magro, “A Systematic Review on Infliximab and Adalimumab Drug Monitoring,” Inflammatory Bowel Diseases, vol. 22, no. 9, pp. 2289–2301, 2016. View at Publisher · View at Google Scholar
  • Irene Franceschet, Nora Cazzagon, Teresa Del Ross, Renata D'Inca, Alessandra Buja, and Annarosa Floreani, “Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new ther,” European Journal Of Gastroenterology & Hepatology, vol. 28, no. 5, pp. 508–513, 2016. View at Publisher · View at Google Scholar
  • Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Amir Hossein Abdolghaffari, Hamid Reza Sodagari, Shadi A. Esfahani, and Nima Rezaei, “A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease,” Expert Review of Gastroenterology & Hepatology, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Nikola Mitrev, and Rupert W. Leong, “Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease,” Expert Opinion on Drug Safety, vol. 16, no. 3, pp. 303–317, 2016. View at Publisher · View at Google Scholar
  • Yosuke Kurashima, and Hiroshi Kiyono, “Physiological and Pathological Inflammation at the Mucosal Frontline,” Chronic Inflammation, pp. 567–590, 2016. View at Publisher · View at Google Scholar
  • Krista M. Reich, Richard N. Fedorak, Karen Madsen, and Karen I. Kroeker, “Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohnʼs Disease,” Inflammatory Bowel Diseases, vol. 22, no. 1, pp. 92–99, 2016. View at Publisher · View at Google Scholar
  • R. Rogers, J. Eastham-Anderson, J. DeVoss, J. Lesch, D. Yan, M. Xu, M. Solon, K. Hotzel, L. Diehl, and J. D. Webster, “Image Analysis-Based Approaches for Scoring Mouse Models of Colitis,” Veterinary Pathology, vol. 53, no. 1, pp. 200–210, 2016. View at Publisher · View at Google Scholar
  • Hyesun Hyun, Seika Hashimoto-Hill, Myunghoo Kim, Michael D Tsifansky, Chang H Kim, and Yoon Yeo, “Succinylated chitosan derivative has local protective effects on intestinal inflammation,” ACS Biomaterials Science & Engineering, 2017. View at Publisher · View at Google Scholar
  • N. Mitrev, N. Vande Casteele, C. H. Seow, J. M. Andrews, S. J. Connor, G. T. Moore, M. Barclay, J. Begun, R. Bryant, W. Chan, C. Corte, S. Ghaly, D. A. Lemberg, V. Kariyawasam, P. Lewindon, J. Martin, R. Mountifield, G. Radford-Smith, P. Slobodian, M. Sparrow, C. Toong, D. van Langenberg, M. G. Ward, and R. W. Leong, “Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases,” Alimentary Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  • S. Tavakolpour, M. Darvishi, and M. Ghasemiadl, “Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases,” Clinical Genetics, vol. 93, no. 3, pp. 481–497, 2018. View at Publisher · View at Google Scholar
  • Michal Walczak, Marzena Skrzypczak-Zielinska, Marianna Plucinska, Oliwia Zakerska-Banaszak, Daria Marszalek, Liliana Lykowska-Szuber, Kamila Stawczyk-Eder, Agnieszka Dobrowolska, and Ryszard Slomski, “Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs,” The Pharmacogenomics Journal, 2018. View at Publisher · View at Google Scholar
  • Ashish Srinivasan, Nik Sheng Ding, Daniel van Langenberg, and Peter De Cruz, “Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Optimising Therapeutic Effectiveness of Biologics,” Biomarkers in Inflammatory Bowel Diseases, pp. 243–255, 2019. View at Publisher · View at Google Scholar
  • Huijuan Wang, Shuhong Zhou, Jiahong Zhang, Shangwen Lei, and Jing Zhou, “Correlations between TLR polymorphisms and inflammatory bowel disease: a meta-analysis of 49 case-control studies,” Immunologic Research, 2019. View at Publisher · View at Google Scholar